Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in AVR and CABG Surgery
NCT01210976Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in left ventricular dysfunction comparing Levosimendan with Placebo (2 arms). Primary endpoint: Blood Pressure up to 5 days. Started Jan 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
left ventricular dysfunction
Beyond the preview
Go deeper on NCT01210976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210976.